(MedPage Today) — SAN FRANCISCO — The investigational selective glucocorticoid receptor modulator relacorilant led to improvements in blood pressure, fasting glucose, and weight for patients with adrenal hypercortisolism, a pair of phase III…
Source link : https://www.medpagetoday.com/meetingcoverage/endo/116508
Author :
Publish date : 2025-07-15 19:03:00
Copyright for syndicated content belongs to the linked Source.
